Wednesday, 30 October 2013

Stem-Cell Therapy Misses Mark in Lymphoma Trial (CME/CE)

(MedPage Today) -- Progression of aggressive non-Hodgkin's lymphoma slowed significantly after autologous stem-cell transplantation, although overall survival did not improve, according to results of a randomized trial. via MedPageToday.com - medical news plus CME for physicians Read More Here..

No comments:

Post a Comment